Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Alopecia areata in Saudi Arabia is costly, mainly due to lost productivity and drug costs.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Tofacitinib may help regrow hair in alopecia areata patients.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Low levels of BDNF and vitamin D are linked to higher depression in alopecia areata and vitiligo patients.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Common baldness is a hereditary condition that can be treated with medications or surgery to prevent progression and improve self-esteem.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Alopecia areata can sometimes appear as a straight line of hair loss instead of round patches.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Early detection and infection prevention are crucial for improving survival in pediatric lupus patients with aplastic anemia.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Trichoscopy is a useful tool for diagnosing and assessing the severity of alopecia areata.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Access to JAK inhibitors for alopecia areata should be improved in the Military Healthcare System.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

Cinainu is effective and safe for treating children's alopecia areata.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Ayurvedic treatments and cupping therapy effectively managed Alopecia totalis.

Certain hair and scalp features indicate a worse outcome in alopecia areata.